Real-world treatment patterns and associated outcomes in patients with HER2-positive unresectable or metastatic breast cancer: the HER2 REAL Study.
BACKGROUND The HER2 REAL (NCT04857619) retrospective study explored treatment practices and survival outcomes in patients with human epidermal growth factor receptor 2 (HER2)-positive unresectable breast cancer/metastatic breast cancer (mBC) in routine clinical care across six countries. METHODS Adult patients (≥18 y...